Dcgi
Recent Highlights
All Stories for Dcgi
Tough regulatory rules likely for sale of codeine-based cough syrups after MPs raise concerns
Himanichandna •Several MPs have demanded the prohibition for the sale of codeine-based cough syrups, which they claim are being used by youngsters for recreational purpose
Govt panel recommends emergency approval for SII's Covovax for 7-11 year olds
•The recommendation has been sent to Drugs Controller General of India (DCGI) for final approval
COVID-19: Bharat Biotech seeks DCGI's permission to conduct Covaxin booster trials in 2-18 age group
•The company has already conducted trials in the age group of 2-18 for two doses of Covaxin
Corbevax, Biological E's COVID-19 vaccine, gets DCGI's emergency use authorisation for children aged 5-12
Fp Staff •The DCGI has also given restricted emergency use authorisation to Covaxin, manufactured by Hyderabad based pharmaceutical company - Bharat Biotech, for children between 6 and 12 years
DCGI clears Bharat Biotech's Covaxin for restricted emergency use in children aged 6-12 years
Fp Staff •Bharat Biotech has been asked to submit safety data alongwith the data on adverse event with due analysis, every 15 days for the first two months and after that monthly data for up to five months
DCGI expert panel holds meet on recommendations to use Corbevax, Covaxin vaccines for 5-12 age group
•India is currently administering two COVID-19 vaccines for children above 12
DCGI grants emergency use permission to Sputnik Light COVID-19 vaccine
•Hyderabad-based Dr Reddy's Laboratories is the Indian partner of the Russian Direct Investment Fund (RDIF), which has sought approval from the Indian drug regulator for use of single-dose Russia's Sputnik Light one shot
Optimus Pharma to launch anti-COVID pill Molnupiravir next week; all you need to know
Fp Staff •Molnupiravir, developed by US-based biotechnology company Ridgeback Biotherapeutics in collaboration with US pharma giant Merck, was approved for emergency use in India on Tuesday
Houston COVID-19 vaccine Corbevax gets DCGI approval for use in India
•The vaccine uses an older recombinant protein yeast fermentation technology similar to that used for the recombinant hepatitis B vaccine which has been around for 40 years.
Hydroxyurea gets DCGI nod for treatment of sickle cell anaemia: all you need to know
Fp Staff •Sickle cell anemia is one of a group of disorders known as sickle cell disease. Sickle cell anemia is an inherited red blood cell disorder in which there aren't enough healthy red blood cells to carry oxygen throughout your body.